Recent advances in the stem cell biology, the biomaterials science, and the design of the tissue culture bioreactors, help us address the growing need to find replacements for lost and worn-out human tissues and organs in an entirely new way. Biological equivalents of native tissues are grown in a laboratory using tissue engineering techniques and investigated for their functionality, both in vitro and in animal models. We briefly review the key principles for engineering these advanced, native-like biomaterials capable to take over the lost function of our tissues. We also provide an example of the state of the art approach to the tissue engineering.
The tissue engineering is an area of science and technology expected to improve our lives, by offering new treatment options for regenerative medicine [1] . By creating biological substitutes of native tissues, the tissue engineering could help us outlive a failure of any of our organs. The overall objective of the whole tissue engineering is to restore the lost tissue function. Engineered tissues of sufficiently high fidelity are also providing physiologically relevant, yet controllable models for the fundamental research -for example, to study native or reprogrammed stem cells in native-like three-dimensional contexts of the development or a disease, or to screen drugs using microarray platforms with engineered human tissues [2] .
Overall, the clinical and scientific utility of the tissue engineering critically depends on our ability to predictably direct the cells to express the right phenotype in the right place and at the right time. We observe that the same factors that regulate the tissue development in vivo (molecular, structural, physical) can be used to direct the cell fate and tissue assembly in vitro. Therefore, the tissue engineering is largely an effort to "imitate nature" as it tends to recapitulate the native environment during the tissue development and remodeling in response to an injury or a disease, and thereby mobilize the regenerative potential of the cells [3, 4] .
A "biomimetic" approach has been developed along these lines, by utilizing the cells (the actual "tissue engineers"), biomaterial scaffolds (structural templates for the tissue formation) and bioreactors (providing environmental control and signaling cascades to guide the tissue formation). The engineering of a human cardiac tissue patch will be used to illustrate the biological requirements and engineering approaches for human applications [5, 6] .
BIOMIMETIC APPROACH
In a living organism, cells are surrounded by other cells and embedded in an extracellular matrix (ECM) that defines the architecture, signaling and biomechanics of the cellular microenvironment. Cellular processes are mediated by molecular, structural and physical cues, and their spatial and temporal gradients. Cells respond to and remodel their immediate microenvironment, via homotypic or heterotypic interactions with neighboring cells, and with the tissue matrix. It is obvious that the biological complexity of the native cell context is not mimicked in the laboratory with standard 2D culture conditions. This is a major limitation to experiments investigating cellular responses in vitro since much of the complex interplay of mechanical and molecular factors present in vivo is absent [5] .
Biomaterial scaffolds provide structural templates for the cell attachment and the tissue growth, whereas bioreactors provide the environmental control. Scaffolds and bioreactors also provide a multi-tude of regulatory signals such as cytokines (diffusing or immobilized) and physical factors (hydrodynamic shear, mechanical stretch, electrical gradients). Both in vivo (during the development and regeneration) and in vitro (for the tissue engineering), the cues presented to cells are the principal determinants of the phenotypic nature and the function of the resultant tissues ( Figure 1 ). The design of the tissue engineering systems is necessarily inspired by biology. The complementary engineering principles help recapitulate the combinations of parameters in the native environments of a specific tissue or organ, in order to orchestrate the conversion of "collections of cells" into specific tissue phenotypes [1] .
Biomaterial scaffolds
An important component to the cell microenvironment is the surrounding matrix, with its cascades of biochemical and physical cues. In a natural setting, cells are embedded in a matrix that is composed of collagens, other proteins, polysaccharides, and water, and has a structure that depends on the location and function of the tissue. For instance, cartilage has high proteoglycan content within a strong collagen network, a matrix that gives this tissue its important mechanical properties to sustain natural loading. In contrast, tendon is highly anisotropic with respect to ECM orientation, making mechanical properties directionally dependent. ECM mechanics can play a role in the differentiation of stem cells and can be engineered into synthetic matrices for directed differentiation. Advances in material synthesis and processing have opened up a range of synthetic and natural materials for use in controlled microenvironments [1] . Materials with a range of molecular, structural and mechanical properties have been designed and utilized for interactions with stem cells, in form of porous, fibrous and hydrogel scaffolds. Porous scaffolds provide macroscopic voids for the migration and infiltration of cells, whereas fibrous scaffolds may be fabricated on a size--scale that mimics the native ECM and may be aligned to control cellular alignment.
Bioreactors
Bioreactors are generally defined as devices in which biological processes (such as cell expansion, differentiation or tissue formation on biomaterial scaf- Figure 1 . Biomimetic approach. In vivo, the cell function and the tissue assembly depend on the culture substrate, the environmental conditions, the supply of nutrients, oxygen and growth factors, and the acting physical factors. These same regulatory factors can be utilized in vitro to engineer functional tissues by an integrated use of isolated cells, biomaterial scaffolds and bioreactors. The cells carry out the process of the tissue formation, in response to regulatory signals. folds) occur under tightly controlled environmental conditions (such as the exchange of oxygen, nutrients and metabolites, the application of molecular and physical regulatory factors). Universal requirements of the bioreactor design include efficient and controllable cell seeding of 3D scaffolds (at a desired cell density, high yield, high kinetic rate, and spatial uniformity) and the improved mass transfer between the gas phase and the culture medium (to control the oxygen supply and pH), and between the scaffold and the culture medium (to control the exchange of nutrients, oxygen and metabolites with the cells) [4] . Typically, a mass transfer in bioreactors occurs by a combination of diffusion and convection, similar to the mass transport in a human body.
A tissue engineering bioreactor should ideally be based on the good understanding of the native environment for the tissue of interest. Tissue-engineering bioreactors are designed to precisely regulate the cellular microenvironment, support cell viability and organization, and provide control of signaling. Bioreactors are also designed to account for specific mechanisms of nutrient transfer and specific physical factors inherent in the native tissue.
CASE STUDY: ENGINEERING A CARDIAC PATCH FOR HEART REPAIR
To describe some of the practical strategies that we currently use to engineer functional grafts and address the challenges we face in translating the tissue engineering into preclinical studies, we will use cardiac tissue engineering as an example. A congestive heart failure, which remains a major health problem without effective therapeutic modalities, is driving the research into cell-based therapies for cardiac repair. Recently, we have utilized human stem cells to derive human cardiovascular cell populations. We have also shown that the use of properly designed scaffolding materials and bioreactors can modulate cell phenotypes and promote functional cell coupling into a contractile cardiac patch (Figure 2 ) [7, 8] . Figure 2 . Cardiac tissue engineering: translation to human cells and large animal studies. The flow chart shows feedbacks between the three major areas of investigation: derivation of cardiac populations of human cells, engineering cardiac patch for cell delivery, and animal studies of heart regeneration. In cell culture studies, cardiac cell populations are derived from human stem cells by application of cytokines and matured by physical stimulation. In tissue engineering studies, these cell populations are cultured on scaffolding materials (suc hydrogels, elastomers, native tissue matrix) in a bioreactor with biophysical signaling, to form a synchronously contractile patch. In animal studies, cells are implanted onto the infarct bed either using a hydrogel as a delivery platform or in form of the cultivated contractile patch. The most promising cell delivery systems are advanced into larger animal studies (sheep or pig) to test the electromechanical coupling in a relevant preclinical model.
The three features of native myocardium: high density of myocytes and supporting cells, efficient oxygen exchange between the cells and blood, and synchronous contractions orchestrated by electrical signal propagation form a set of design requirements for engineering cardiac tissue [6] .
Our laboratory has developed a "biomimetic" approach to the cardiac tissue engineering that involves an integrated use of cells, biomaterial scaffolds and bioreactors to engineer compact, millimeters-thick, synchronously contracting cardiac tissue constructs. Two main design considerations are to provide: (1) convective-diffusive oxygen transport (critical for cell survival and function) and (2) excitation-contraction coupling (critical for cell differentiation and assembly) [6] [7] [8] .
To mimic the capillary network, cells were cultured on porous scaffolds with an array of channels perfused with the culture medium (to provide a separate compartment for the medium flow) and the medium was supplemented with an oxygen carrier (to mimic the role of hemoglobin). This approach tends to provide in vivo like mechanisms of the oxygen supply to cultured cells and can overcome both the inherent limitations of a diffusion transport in conventional culture systems and the adverse effects of shear in perfused non-channeled tissue constructs.
In native heart, mechanical stretch is induced by electrical signals and the orderly coupling between electrical pacing signals and macroscopic contractions is crucial for the development and function of native myocardium. Electrical signals designed to induce synchronous construct contractions during cultivation resulted in the progressive development of conductive and contractile properties.
Our ongoing studies are directed towards advancing our fundamental understanding of the unique properties of human stem cells and their utilization to treat a cardiac disease. Specifically, we are trying to make progress in two directions: (1) maturation of human cardiac and vascular cell phenotypes by biophysical stimulation during the culture and (2) the provision of suitable delivery platforms enabling a cell retention and environmental conditioning in ischemic myocardium. This work is based on the premise that unlocking the regenerative potential of human embryonic stem cells requires a reconstruction of some of the keys as key aspects found in the dynamic environments during the native development and regeneration. We expect that developmentally inspired physical signals can be utilized to mature the phenotype of human cardiac progenitors derived from embryonic stem cells.
